Sunitinib malate 25 mg/1 (Sunitinib malate CAPSULE) 25 mg/1

Sunitinib malate 25 mg capsules are a pharmaceutical product used for targeted therapy. This oral medication is designed to support specific treatment protocols as prescribed by healthcare professionals.

Strength

25 mg/1

Pack Size

28 CAPSULE in 1 BOTTLE (16714-677-01)

Manufacturer / TM Owner

NorthStar RxLLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sunitinib malate is primarily used in the management of certain types of cancer. It works by targeting specific proteins involved in the growth and spread of cancer cells. Patients often wonder, 'What is Sunitinib malate used for?' This medication is typically prescribed for advanced or metastatic cancers, though specific uses may vary based on individual health conditions.

Side Effects

Common effects of Sunitinib malate may include fatigue, nausea, and skin discoloration. Some users also report changes in taste or mild gastrointestinal discomfort. These effects can vary widely among individuals and are not experienced by everyone who takes the medication.

Precautions & Warnings

Sunitinib malate should be handled with care, following the guidelines provided by a healthcare professional. It is important to store the capsules in a cool, dry place away from direct sunlight. Patients should avoid crushing or breaking the capsules unless directed to do so.

Avoid Interactions

Sunitinib malate may interact with certain medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, grapefruit and grapefruit juice should be avoided as they can affect the metabolism of Sunitinib malate.

Frequently Asked Questions

Sunitinib malate is used in the treatment of certain types of cancer, targeting specific proteins involved in cancer cell growth.

Store Sunitinib malate capsules in a cool, dry place away from direct sunlight and out of reach of children.

Sunitinib malate may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Common side effects may include fatigue, nausea, skin discoloration, and changes in taste.

Grapefruit and grapefruit juice should be avoided as they can affect the metabolism of Sunitinib malate.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.